Ticker: Biogen to stop selling Alzheimer ’s drug; WynnBet, Betr look to exit Mass. mobile sports betting

Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago. The Cambridge-based drugmaker also said Wednesday that it will end a study of the drug needed for full approval from the Food and Drug…#biogen #cambridge #eisai #leqembi #fda #wynnbet #mass #massachusetts #betr #massgamingcommission
Source: Reuters: Health - Category: Consumer Health News Source Type: news